Wealth Preservation Advisors’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Wealth Preservation Advisors’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-52,600	Closed	-$2.68K	–	1018
2026 Q1	$2.68K	Hold	52,600	–	–	﹤0.01%	560
2025 Q4	$2.94K	Hold	52,600	–	–	﹤0.01%	466
2025 Q3	$4.68K	Buy	52,600 +600	+1%	+$53	﹤0.01%	376
2025 Q2	$3.9K	Hold	52,000	–	–	﹤0.01%	393
2025 Q1	$5.2K	Buy	+52,000	New	+$5.2K	﹤0.01%	374

Other funds holding PVCT

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Atlas Wealth Cincinnati, Ohio $701M AUM 15.28% 1-Year Est. Return

Financial Symmetry Raleigh, North Carolina $300M AUM 23.79% 1-Year Est. Return

Wealth Preservation Advisors's PVCT Position: Q2 2026 in Review

Wealth Preservation Advisors sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q2 2026, closing a stake of 52,600 shares — an estimated $2.68K sold.

Wealth Preservation Advisors first reported a position in PVCT in Q1 2025 and held it in 5 quarters. The position peaked at $5.2K in Q1 2025. 4 funds tracked by Wall St. Rank hold PVCT as of Q2 2026.

Wealth Preservation Advisors reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q2 2026 after selling out during the quarter.
Wealth Preservation Advisors sold 52,600 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q2 2026, an estimated $2.68K.
Wealth Preservation Advisors first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q1 2025 and held it in 5 quarters.
Wealth Preservation Advisors's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $5.2K in Q1 2025.
4 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q2 2026.

Based on Wealth Preservation Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.